Abstract
Discovery of biomedical drugs makes use of novel biological sources of limited availability and is often in need of fast, small-scale initial screening approaches. Here, we present a screening, based on the reporter Caenorhabditis elegans strain IG692, for identification of anti- and pro-inflammatory properties. The elaborated workflow is based on cultivation in fluid and by this, allows fast and reproducible seeding in 96 well plates. LPS and dexamethasone served as reliable controls, comparable to application in the human cell line THP-1. This in vivo approach offers a first step for selection of e.g. natural products or for repurposing of compounds from drug libraries and by this can serve as a tool in drug discovery for inflammatory human diseases.
Funding source: Ministerium für Wissenschaft und Gesundheit Rheinland-Pfalz
Award Identifier / Grant number: NeurodegX
Acknowledgements
The authors would like to acknowledge Andreas Kern and Christian Behl (Pathobiochemistry, Johannes Gutenberg-University Mainz) for their kind help with initiating C. elegans experiments. The C. elegans strain was provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).
-
Author contributions: K. E. drafted the manuscript and provided the scheme, V. T. T. N., S. M. and H. R. conducted experiments and drew the Figures. V. T. T. N., S. M. and H. R. proof-read and edited the manuscript. All authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: The work of K. E. and V. T. T. N. is supported by the MWG (Forschungskolleg NeurodegX).
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
Aballay, A., Drenkard, E., Hilbun, L.R., and Ausubel, F.M. (2003). Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway. Curr. Biol. 13: 47–52, https://doi.org/10.1016/s0960-9822(02)01396-9.Search in Google Scholar PubMed
Brandt, J.P. and Ringstad, N. (2015). Toll-like receptor signaling promotes development and function of sensory neurons required for a C. elegans pathogen-avoidance behavior. Curr. Biol. 25: 2228–2237, https://doi.org/10.1016/j.cub.2015.07.037.Search in Google Scholar PubMed PubMed Central
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77: 71–94, https://doi.org/10.1093/genetics/77.1.71.Search in Google Scholar PubMed PubMed Central
Coghlan, M.J., Elmore, S.W., Kym, P.R., and Kort, M.E. (2003). The pursuit of differentiated ligands for the glucocorticoid receptor. Curr. Top. Med. Chem. 3: 1617–1635, https://doi.org/10.2174/1568026033451718.Search in Google Scholar PubMed
Couillault, C., Pujol, N., Reboul, J., Sabatier, L., Guichou, J.F., Kohara, Y., and Ewbank, J.J. (2004). TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 5: 488–494, https://doi.org/10.1038/ni1060.Search in Google Scholar PubMed
Darby, C. (2005). Interactions with microbial pathogens. WormBook: 1–15, https://doi.org/10.1895/wormbook.1.21.1.Search in Google Scholar PubMed PubMed Central
Fay, D.S., Fluet, A., Johnson, C.J., and Link, C.D. (1998). In vivo aggregation of beta-amyloid peptide variants. J. Neurochem. 71: 1616–1625, https://doi.org/10.1046/j.1471-4159.1998.71041616.x.Search in Google Scholar PubMed
Hunt, P.R., Olejnik, N., Bailey, K.D., Vaught, C.A., and Sprando, R.L. (2018). C. elegans development and activity test detects mammalian developmental neurotoxins. Food Chem. Toxicol. 121: 583–592, https://doi.org/10.1016/j.fct.2018.09.061.Search in Google Scholar PubMed
Irazoqui, J.E., Urbach, J.M., and Ausubel, F.M. (2010). Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat. Rev. Immunol. 10: 47–58, https://doi.org/10.1038/nri2689.Search in Google Scholar PubMed PubMed Central
Jadiya, P., Khan, A., Sammi, S.R., Kaur, S., Mir, S.S., and Nazir, A. (2011). Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson’s disease. Biochem. Biophys. Res. Commun. 413: 605–610, https://doi.org/10.1016/j.bbrc.2011.09.010.Search in Google Scholar PubMed
Kaletta, T. and Hengartner, M.O. (2006). Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5: 387–398, https://doi.org/10.1038/nrd2031.Search in Google Scholar PubMed
Kurz, C.L. and Ewbank, J.J. (2003). Caenorhabditis elegans: an emerging genetic model for the study of innate immunity. Nat. Rev. Genet. 4: 380–390, https://doi.org/10.1038/nrg1067.Search in Google Scholar PubMed
Leung, C.K., Deonarine, A., Strange, K., and Choe, K.P. (2011). High-throughput screening and biosensing with fluorescent C. elegans strains. J Vis Exp 51: e2745, https://doi.org/10.3791/2745.Search in Google Scholar PubMed PubMed Central
Liberati, N.T., Fitzgerald, K.A., Kim, D.H., Feinbaum, R., Golenbock, D.T., and Ausubel, F.M. (2004). Requirement for a conserved toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response. Proc. Natl. Acad. Sci. U. S. A. 101: 6593–6598, https://doi.org/10.1073/pnas.0308625101.Search in Google Scholar PubMed PubMed Central
Mazzeo, L.E.M., Dersh, D., Boccitto, M., Kalb, R.G., and Lamitina, T. (2012). Stress and aging induce distinct polyQ protein aggregation states. Proc. Natl. Acad. Sci. U. S. A. 109: 10587–10592, https://doi.org/10.1073/pnas.1108766109.Search in Google Scholar PubMed PubMed Central
Nass, R. and Hamza, I. (2007). The nematode C. elegans as an animal model to explore toxicology in vivo: solid and axenic growth culture conditions and compound exposure parameters. Curr. Protoc. Toxicol., Chapter 1, Unit 1.9.1–1.9.18, https://doi.org/10.1002/0471140856.tx0109s31.Search in Google Scholar PubMed
Nathoo, A.N., Moeller, R.A., Westlund, B.A., and Hart, A.C. (2001). Identification of neuropeptide-like protein gene families in Caenorhabditis elegans and other species. Proc. Natl. Acad. Sci. U. S. A. 98: 14000–14005, https://doi.org/10.1073/pnas.241231298.Search in Google Scholar PubMed PubMed Central
Pujol, N., Cypowyj, S., Ziegler, K., Millet, A., Astrain, A., Goncharov, A., Jin, Y., Chisholm, A.D., and Ewbank, J.J. (2008a). Distinct innate immune responses to infection and wounding in the C. elegans epidermis. Curr. Biol. 18: 481–489, https://doi.org/10.1016/j.cub.2008.02.079.Search in Google Scholar PubMed PubMed Central
Pujol, N., Zugasti, O., Wong, D., Couillault, C., Kurz, C.L., Schulenburg, H., and Ewbank, J.J. (2008b). Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides. PLoS Pathog. 4: e1000105, https://doi.org/10.1371/journal.ppat.1000105.Search in Google Scholar PubMed PubMed Central
Schulenburg, H. and Felix, M.A. (2017). The natural biotic environment of Caenorhabditis elegans. Genetics 206: 55–86, https://doi.org/10.1534/genetics.116.195511.Search in Google Scholar PubMed PubMed Central
Shafee, T.M., Lay, F.T., Phan, T.K., Anderson, M.A., and Hulett, M.D. (2017). Convergent evolution of defensin sequence, structure and function. Cell. Mol. Life Sci. 74: 663–682, https://doi.org/10.1007/s00018-016-2344-5.Search in Google Scholar PubMed
Singh, R., Chandrashekharappa, S., Vemula, P.K., Haribabu, B., and Jala, V.R. 2020. Microbial metabolite urolithin B inhibits recombinant human monoamine oxidase A enzyme. Metabolites 10: 258, https://doi.org/10.3390/metabo10060258.Search in Google Scholar PubMed PubMed Central
Teuscher, A.C. and Ewald, C.Y. (2018). Overcoming autofluorescence to assess GFP expression during normal physiology and aging in Caenorhabditis elegans. Bio-Protocol 8: e2940, https://doi.org/10.21769/BioProtoc.2940.Search in Google Scholar PubMed PubMed Central
Vaure, C. and Liu, Y. (2014). A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front. Immunol. 5: 316, https://doi.org/10.3389/fimmu.2014.00316.Search in Google Scholar PubMed PubMed Central
Veriepe, J., Fossouo, L., and Parker, J.A. (2015). Neurodegeneration in C. elegans models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons. Nat. Commun. 6: 7319, https://doi.org/10.1038/ncomms8319.Search in Google Scholar PubMed
Wilson, R.K. (1999). How the worm was won. The C. elegans genome sequencing project. Trends Genet. 15: 51–58, https://doi.org/10.1016/s0168-9525(98)01666-7.Search in Google Scholar PubMed
Yasuda, K., Kubo, Y., Murata, H., and Sakamoto, K. (2021). Cortisol promotes stress tolerance via DAF-16 in Caenorhabditis elegans. Biochem. Biophys. Rep. 26: 100961, https://doi.org/10.1016/j.bbrep.2021.100961.Search in Google Scholar PubMed PubMed Central
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Highlight: Drug Development for Neurodegenerative Diseases
- Drug development for neurodegenerative diseases
- The role of mycotoxins in neurodegenerative diseases: current state of the art and future perspectives of research
- Emerging contributions of formyl peptide receptors to neurodegenerative diseases
- Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer’s disease
- Artemisinin-treatment in pre-symptomatic APP-PS1 mice increases gephyrin phosphorylation at Ser270: a modification regulating postsynaptic GABAAR density
- Anti-inflammatory dihydroxanthones from a Diaporthe species
- The antioxidant Rutin counteracts the pathological impact of α-synuclein on the enteric nervous system in vitro
- A liquid-culture-based screening approach to study compounds affecting inflammatory processes in Caenorhabditis elegans
Articles in the same Issue
- Frontmatter
- Highlight: Drug Development for Neurodegenerative Diseases
- Drug development for neurodegenerative diseases
- The role of mycotoxins in neurodegenerative diseases: current state of the art and future perspectives of research
- Emerging contributions of formyl peptide receptors to neurodegenerative diseases
- Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer’s disease
- Artemisinin-treatment in pre-symptomatic APP-PS1 mice increases gephyrin phosphorylation at Ser270: a modification regulating postsynaptic GABAAR density
- Anti-inflammatory dihydroxanthones from a Diaporthe species
- The antioxidant Rutin counteracts the pathological impact of α-synuclein on the enteric nervous system in vitro
- A liquid-culture-based screening approach to study compounds affecting inflammatory processes in Caenorhabditis elegans